Germany· DE-A57-c8c77ec83eaabf2c
Cefasept N Zur Anwendung Bei Kindern Ab 6 Jahren Und Erwachsenen
A medicinal product containing echinacea mother tincture, hydrargyrum bicyanatum d8, kalium phosphoricum d4, lachesis mutus dil d6, registered in Germany by Cefak Kg.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Echinacea Mother Tincture, Hydrargyrum Bicyanatum D8, Kalium Phosphoricum D4, Lachesis Mutus Dil D6
- Manufacturer
- Cefak Kg
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a5c534f8-e200-47a3-aac3-3222eefb1a18 GET /v1/drugs/a5c534f8-e200-47a3-aac3-3222eefb1a18?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Echinacea Mother Tincture, Hydrargyrum Bicyanatum D8, Kalium Phosphoricum D4, Lachesis Mutus Dil D6",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about echinacea mother tincture, hydrargyrum bicyanatum d8, kalium phosphoricum d4, lachesis mutus dil d6.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.